PLUS THERAPEUTICS, INC. (PSTV)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PLUS THERAPEUTICS, INC. reported revenue of $5.21M, down 10.5% from the prior year. The company ran a net loss, with a net margin of -429.4%. It held $16.32M in total assets against $12.33M in total liabilities.
Key ratios (FY2025)
-293.5%
Operating margin
-429.4%
Net margin
-560.2%
Return on equity
-10.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.21M | $5.82M | $4.91M | — | — | — | — | — | $2.69M | $4.66M |
| Cost of Revenue | — | — | — | — | — | — | — | $1.15M | $1.32M | — |
| Gross Profit | — | — | — | — | — | — | — | — | $146.0K | $1.94M |
| Operating Income | -$15.30M | -$14.70M | -$13.32M | -$19.71M | -$12.49M | -$9.58M | -$3.66M | -$8.76M | -$20.68M | -$19.71M |
| Net Income | -$22.39M | -$12.98M | -$13.32M | -$20.27M | -$13.40M | -$8.24M | -$10.89M | -$12.63M | -$22.69M | -$22.05M |
| EPS (Diluted) | $-0.29 | $-2.34 | $-4.24 | $-11.58 | $-1.11 | — | — | — | — | — |
| Total Assets | $16.32M | $6.63M | $11.39M | $23.87M | $21.98M | $12.11M | $23.23M | $23.99M | $31.61M | $34.61M |
| Total Liabilities | $12.33M | $15.58M | $12.74M | $17.42M | $11.14M | $9.07M | $22.07M | $18.77M | $18.61M | $23.62M |
| Shareholders' Equity | $4.00M | -$8.95M | -$1.35M | $6.45M | $10.84M | $3.03M | $1.16M | $5.22M | $13.00M | $10.99M |
| Cash & Equivalents | $4.26M | $76.0K | $8.55M | $18.12M | $18.40M | $8.35M | $17.55M | $5.26M | $9.55M | $12.60M |
| Operating Cash Flow | -$20.77M | -$10.55M | -$12.85M | -$12.97M | -$10.28M | -$8.43M | -$5.91M | -$11.97M | -$18.13M | — |
| Capital Expenditures | $67.0K | $146.0K | $160.0K | — | — | — | $67.0K | $133.0K | $295.0K | $67.0K |
| Shares Outstanding | 138.68M | 5.90M | 4.44M | 2.24M | 15.51M | 6.75M | 3.88M | 296.6K | 5.78M | 21.71M |